chemyo retatrutide (sodium salt) (LY3437943) Retatrutide Peptide 20mg (RUO) |

Clinical trial data from Eli Lillys Phase 2 study showed that the 12mg weekly dose produced an average weight loss of 24.2% over 48 weeks, with over 80% of participants losing at least 15% of their starting body weight

The pellets were placed in each side of the cage for double-housed mice and the mice were treated with isotonic saline

Use single-use needles and syringes only never share equipment between individuals

Retatrutide is a triple-agonist (GLP-1, GIP, glucagon) while Mounjaro is a dual-agonist (GLP-1, GIP)

For someone struggling with weight management, these biological changes can significantly reduce food noise and help support long-term weight loss goals